Literature DB >> 24274178

DNA sequencing of cancer: what have we learned?

Juliann Chmielecki1, Matthew Meyerson.   

Abstract

DNA sequencing has taught us much about the structure of cancer genomes and enabled the discovery of novel genes that drive and maintain tumorigenesis. With the advent and application of next-generation massively parallel sequencing technologies, one can rapidly generate and analyze data from the cellular "-omes": genomes, exomes, and transcriptomes. This review highlights recent genomic discoveries in signal transduction, metabolism, epigenetic modifications, cell cycle and genome maintenance, RNA processing, and transcription. Additionally, genomic sequencing has revealed the complexity of the cancer genome and has enabled the discovery of functional rearrangements with therapeutic and diagnostic potentials.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24274178     DOI: 10.1146/annurev-med-060712-200152

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  20 in total

Review 1.  Cell death in genome evolution.

Authors:  Xinchen Teng; J Marie Hardwick
Journal:  Semin Cell Dev Biol       Date:  2015-02-25       Impact factor: 7.727

2.  The Potential Predictors in Chemotherapy Sensitivity.

Authors:  Eun-Kyu Kim; Hee-Chul Shin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Effect of cytostatic proline rich polypeptide-1 on tumor suppressors of inflammation pathway signaling in chondrosarcoma.

Authors:  Karina Galoian; Shihua Luo; Amir Qureshi; Parthik Patel; Rachel Price; Ashlyn S Morse; Gor Chailyan; Silva Abrahamyan; H T Temple
Journal:  Mol Clin Oncol       Date:  2016-09-02

4.  Oncogenic alterations in ERBB2/HER2 represent potential therapeutic targets across tumors from diverse anatomic sites of origin.

Authors:  Juliann Chmielecki; Jeffrey S Ross; Kai Wang; Garrett M Frampton; Gary A Palmer; Siraj M Ali; Norma Palma; Deborah Morosini; Vincent A Miller; Roman Yelensky; Doron Lipson; Philip J Stephens
Journal:  Oncologist       Date:  2014-12-05

Review 5.  Bioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancer.

Authors:  Tim N Beck; Adaeze J Chikwem; Nehal R Solanki; Erica A Golemis
Journal:  Physiol Genomics       Date:  2014-08-05       Impact factor: 3.107

Review 6.  Genomic and Epigenomic Alterations in Cancer.

Authors:  Balabhadrapatruni V S K Chakravarthi; Saroj Nepal; Sooryanarayana Varambally
Journal:  Am J Pathol       Date:  2016-07       Impact factor: 4.307

Review 7.  Beyond histology: translating tumor genotypes into clinically effective targeted therapies.

Authors:  Catherine B Meador; Christine M Micheel; Mia A Levy; Christine M Lovly; Leora Horn; Jeremy L Warner; Douglas B Johnson; Zhongming Zhao; Ingrid A Anderson; Jeffrey A Sosman; Cindy L Vnencak-Jones; Kimberly B Dahlman; William Pao
Journal:  Clin Cancer Res       Date:  2014-03-05       Impact factor: 12.531

Review 8.  Biomolecular Condensates and Cancer.

Authors:  Ann Boija; Isaac A Klein; Richard A Young
Journal:  Cancer Cell       Date:  2021-01-07       Impact factor: 31.743

Review 9.  Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes.

Authors:  Tony Shen; Stefan Hans Pajaro-Van de Stadt; Nai Chien Yeat; Jimmy C-H Lin
Journal:  Front Genet       Date:  2015-06-17       Impact factor: 4.599

10.  Empirical evaluation of methods for de novo genome assembly.

Authors:  Firaol Dida; Gangman Yi
Journal:  PeerJ Comput Sci       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.